Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Haiyang Liang"'
Autor:
Huizhe Xu, Ye Zhang, Jia Liu, Jing Cui, Yu Gan, Zhisheng Wu, Youwei Chang, Rui Sui, Yi Chen, Ji Shi, Haiyang Liang, Qiang Liu, Shulan Sun, Haozhe Piao
Publikováno v:
Cancers, Vol 14, Iss 21, p 5343 (2022)
UM-164 is a dual inhibitor of c-Src and p38 MAPK, and has been a lead compound for targeting triple-negative breast cancer. UM-164 shows stronger binding to the active sites of Src compared with the conventional Src inhibitor Dasatinib. While Dasatin
Externí odkaz:
https://doaj.org/article/1c373fdbf2734273afe451b3823c4355